Search clinical trials for: Hematopoietic progenitor kinase 1 (HPK1)

Total 56674 results

Eli Lilly and Company

Active, not recruiting

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)

Ulcerative Colitis

Spain, United States, China, Australia, Austria, Japan, Hungary, Taiwan, Russian Federation, Canada, Korea, Republic of, Italy, Belgium, Poland, Switzerland, Argentina, India, Israel, Latvia, Ukraine, Denmark, Mexico, Romania, Malaysia, Netherland... and more
Eli Lilly and Company

Active, not recruiting

Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer (postMONARCH)

Neoplasm Metastasis | Breast Neoplasm

United States, Hungary, Italy, Czechia, Taiwan, Turkey, Belgium, Spain, Korea, Republic of, Israel, Argentina, Greece, France, Mexico, Sweden, Denmark, Poland
Eli Lilly and Company

Active, not recruiting

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) (QWINT-1)

Type 2 Diabetes | T2D

United States, Mexico, Argentina, Puerto Rico
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) (SURPASS-SWITCH)

Type 2 Diabetes

United States, Belgium, Germany, Mexico, Romania
Eli Lilly and Company

Active, not recruiting

A Study of LY3561774 in Participants With Mixed Dyslipidemia (PROLONG-ANG3)

Metabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hyperlipoproteinemia

United States, Mexico, Poland, Canada, Turkey, Japan, Argentina
Eli Lilly and Company

Completed

A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes (RescuiNGkids)

Type 1 Diabetes

United States
Eli Lilly and Company

Completed

A Study to Compare Two Formulations of LY3209590 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events (KRAKEN)

Lipoprotein Disorder

Australia, China, Hungary, Brazil, Japan, Germany, Netherlands, United States
Eli Lilly and Company

Completed

A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia

Hypertriglyceridemia

Singapore
Eli Lilly and Company

Active, not recruiting

A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities

Obesity | Overweight

China
Eli Lilly and Company

Completed

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India

Diabetes Mellitus, Type 2

India
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)

Diabetes Mellitus, Type 2 | Type 2 Diabetes

United States
Eli Lilly and Company

Completed

A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

China
Eli Lilly and Company

Completed

A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

Healthy | Renal Insufficiency

United States
Ningbo No. 1 Hospital
Zhejiang University

Recruiting

CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL

Diffuse Large B-cell Lymphoma

China
Ningbo No. 1 Hospital
Peking University

Active, not recruiting

Optimizing Intervention Effects in Children and Adolescents

Childhood Obesity

China
University of Florida
Alpha-1 Foundation

Enrolling by invitation

Alpha-1 Foundation DNA and Tissue Bank

Alpha 1 Antitrypsin Deficiency

United States
Eli Lilly and Company

Completed

A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non Small Cell Lung

Taiwan, Japan, Korea, Republic of, China
Eli Lilly and Company

Terminated

A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma

United States
Eli Lilly and Company

Not yet recruiting

A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight

Healthy | Obesity | Overweight | Obese

United States
Eli Lilly and Company

Completed

A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants

Healthy

United States
Eli Lilly and Company

Completed

A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants

Healthy

United States
Hospices Civils de Lyon

Completed

Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort (Polygen)

Children With a Deficiency of Alpha-1 Antitrypsin

France
Alvotech Swiss AG

Completed

PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)

Phase 1

New Zealand
Saniona

Completed

A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate

Phase 1

Germany
Calliditas Therapeutics AB
Eurofins Optimed; York Bioanalytical Solution

Completed

Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets

Phase 1

France
Calliditas Therapeutics AB

Completed

Study to Evaluate the Pharmacokinetics and Drug-Drug Interactions of Setanaxib in Healthy Adult Male and Female Subjects

Phase 1

France
Charite University, Berlin, Germany
Hospital del Mar

Completed

Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria (PAFCUTIII)

Cold Contact Urticaria

Germany
Genfit

Completed

Pilot Study With GFT505 (80mg) in Patients With Insulin Resistance and Abdominal Obesity

Insulin Resistance | Abdominal Obesity

France
Wakayama Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer

Esophageal Cancer

Japan
IWK Health Centre
Canadian Institutes of Health Research (CIHR)

Not yet recruiting

Connecting Families to Improve Parental Self-efficacy and Parent Psychosocial and Infant Health Outcomes in the NICU

Mental Health Wellness 1 | Self Efficacy | eHealth | Infant Development
Rigshospitalet, Denmark
Department of Cardiovascular and Renal Research, University of Southern Denmark

Completed

Acute Effects of GLP-1 on Renal Hemodynamics (GLP1RRBF)

The GLP-1-mediated Gut-kidney Axis

Denmark
National University Hospital, Singapore
National University, Singapore; The N.1 Institute for Health (N.1)

Recruiting

CURATE.AI COR-Tx Trial for Post Brain Radiotherapy Patients

Cognitive Decline

Singapore
Eisai Inc.

Completed

Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures

Partial-Onset or Primary Generalized Tonic-Clonic Seizures

Canada, France, Italy, Korea, Republic of, Spain, United States, Belgium, Czechia, Hungary, Japan, Latvia, Poland
Fundació Universitària del Bages

Not yet recruiting

Promoting a Healthy Life Through Gender Equity (Uni4Move)

Mental Health Wellness 1 | Sedentary Behavior | Physical Inactivity | Gender Discrimination

Spain
Chinese University of Hong Kong

Not yet recruiting

Randomized Controlled Trial on Precision Mental Health

Mental Health Wellness 1 | Mental Well-being | Mental Health Issue | Precision Mental Health

Hong Kong
Universidad del Valle, Colombia
Universidad de la Sabana

Completed

Emotional Intelligence Program for Adolescents With Antisocial Behavior (DYNAMIS) (DYNAMIS)

Mental Health Wellness 1

Colombia
China Medical University Hospital
National Science Council, Taiwan

Unknown

Health Promotion on Young Adults With High Risk Disability for Mental Health (HPMI)

Mental Health Wellness 1

Taiwan
Eisai Inc.
Merck Sharp & Dohme LLC

Completed

A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile

Thyroid Cancer

United States, Canada, Germany, Korea, Republic of, Spain, France, Australia, Belgium, Denmark, Israel, Italy, Poland, Romania, Russian Federation, Sweden, United Kingdom
Genzyme, a Sanofi Company

Completed

Manageability and Safety Assessment of Sepraspray in Abdominal Surgery. (C-MUST)

Adhesion Prevention

France
Eisai Co., Ltd.

Completed

A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma

Neoplasms | Carcinoma | Neoplasms, Glandular and Epithelial | Carcinoma, Hepatocellular

Japan
Eisai Co., Ltd.

Completed

Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)

Carcinoma, Renal Cell

Japan
Ablynx

Withdrawn

Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection

Respiratory Syncytial Virus Lower Respiratory Tract Infection

Belgium, Spain, Australia
Eli Lilly and Company

Completed

Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

Canada, United States
Zhejiang Cancer Hospital

Recruiting

Lenvatinib Combined With Tislelizumab and TACE Applied as Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma With High-risk Recurrence Factors

Hepatocellular Carcinoma | Oxaliplatin | TACE | Lenvatinib | Tislelizumab | Pharmorubicin

China
Amsterdam UMC, location VUmc
Radboud University Medical Center; Maastricht University Medical Center; GGZ... and other collaborators

Recruiting

TMS for Exposure Therapy Resistant OCD (TETRO)

1 Hz Real rTMS to the Pre-SMA | 1 Hz Sham rTMS to the Pre-SMA

Netherlands
ArQule, Inc. (a wholly owned subsidiary of Merck...

Completed

A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

United States, Poland, Germany, Russian Federation, Latvia, Ukraine
Conor Medsystems

Terminated

CoStar Catheter System Evaluation (CONCISE)

Symptomatic Ischemic Heart Disease

Germany
Assistance Publique - Hôpitaux de Paris

Completed

Study of the Relationship Between Dose-concentration-effect of Delta-9-tetrahydrocannabinol (THC) and the Ability to Drive in Chronic or Occasional Cannabis Users (VIGICANN)

Occasional (1-2 Joints Per Week) and Chronic (1-2 Joints Per Day) Cannabis Users

France
UCB BIOSCIENCES GmbH

Completed

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects

Healthy

Germany

Search clinical trials for: Hematopoietic progenitor kinase 1 (HPK1)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations